Skip to main content

Main menu

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Subscribers
    • Advertisers
    • Editorial Board
    • Special Issues
  • Journal Metrics
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics

User menu

  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Anticancer Research
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics
  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Anticancer Research

Advanced Search

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Subscribers
    • Advertisers
    • Editorial Board
    • Special Issues
  • Journal Metrics
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Visit us on Facebook
  • Follow us on Linkedin
Research ArticleClinical Studies

Association Between Body Mass Index and Outcomes in Patients With Urothelial Carcinoma Treated With Pembrolizumab

IKKO TOMISAKI, MIRII HARADA, SHIGERU SAKANO, MICHIKAZU TERADO, RYOICHI HAMASUNA, SHUJI HARADA, HIROOMI MATSUMOTO, SOICHIRO AKASAKA, YUJIRO NAGATA, AKINORI MINATO, KEN-ICHI HARADA and NAOHIRO FUJIMOTO
Anticancer Research January 2023, 43 (1) 269-274; DOI: https://doi.org/10.21873/anticanres.16159
IKKO TOMISAKI
1Department of Urology, University of Occupational and Environmental Health, Kitakyushu, Japan;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: ikko{at}med.uoeh-u.ac.jp
MIRII HARADA
1Department of Urology, University of Occupational and Environmental Health, Kitakyushu, Japan;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
SHIGERU SAKANO
2Department of Urology, Kokura Memorial Hospital, Kitakyushu, Japan;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
MICHIKAZU TERADO
3Department of Urology, Munakata Suikokai General Hospital, Fukutsu, Japan;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
RYOICHI HAMASUNA
4Department of Urology, Shin-kokura Hospital, Kitakyushu, Japan;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
SHUJI HARADA
5Department of Urology, Shin-yukuhashi Hospital, Yukuhashi, Japan;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
HIROOMI MATSUMOTO
6Department of Urology, Kitakyushu City Yahata Hospital, Kitakyushu, Japan;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
SOICHIRO AKASAKA
7Department of Urology, Moji Medical Centre, Kitakyushu, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
YUJIRO NAGATA
1Department of Urology, University of Occupational and Environmental Health, Kitakyushu, Japan;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
AKINORI MINATO
1Department of Urology, University of Occupational and Environmental Health, Kitakyushu, Japan;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
KEN-ICHI HARADA
1Department of Urology, University of Occupational and Environmental Health, Kitakyushu, Japan;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
NAOHIRO FUJIMOTO
1Department of Urology, University of Occupational and Environmental Health, Kitakyushu, Japan;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

Article Information

vol. 43 no. 1 269-274
DOI 
https://doi.org/10.21873/anticanres.16159
PMID 
36585166

Published By 
International Institute of Anticancer Research
Print ISSN 
0250-7005
Online ISSN 
1791-7530
History 
  • Received November 13, 2022
  • Revision received November 25, 2022
  • Accepted November 28, 2022
  • Published online December 30, 2022.

Copyright & Usage 
Copyright © 2023 International Institute of Anticancer Research (Dr. George J. Delinasios), All rights reserved.

Author Information

  1. IKKO TOMISAKI1⇑,
  2. MIRII HARADA1,
  3. SHIGERU SAKANO2,
  4. MICHIKAZU TERADO3,
  5. RYOICHI HAMASUNA4,
  6. SHUJI HARADA5,
  7. HIROOMI MATSUMOTO6,
  8. SOICHIRO AKASAKA7,
  9. YUJIRO NAGATA1,
  10. AKINORI MINATO1,
  11. KEN-ICHI HARADA1 and
  12. NAOHIRO FUJIMOTO1
  1. 1Department of Urology, University of Occupational and Environmental Health, Kitakyushu, Japan;
  2. 2Department of Urology, Kokura Memorial Hospital, Kitakyushu, Japan;
  3. 3Department of Urology, Munakata Suikokai General Hospital, Fukutsu, Japan;
  4. 4Department of Urology, Shin-kokura Hospital, Kitakyushu, Japan;
  5. 5Department of Urology, Shin-yukuhashi Hospital, Yukuhashi, Japan;
  6. 6Department of Urology, Kitakyushu City Yahata Hospital, Kitakyushu, Japan;
  7. 7Department of Urology, Moji Medical Centre, Kitakyushu, Japan
  1. Correspondence to: Ikko Tomisaki, Department of Urology, University of Occupational and Environmental Health, 1-1 Iseigaoka Yahatanishi-ku, Kitakyushu City, Fukuoka 807-8555, Japan. Tel: +81 936917446, Fax: +81 936038724, e-mail: ikko{at}med.uoeh-u.ac.jp
View Full Text

Statistics from Altmetric.com

Cited By...

  • 3 Citations
  • Citations
  • Google Scholar

This article has not yet been cited by articles in journals that are participating in Crossref Cited-by Linking.

PreviousNext
Back to top

In this issue

Anticancer Research: 43 (1)
Anticancer Research
Vol. 43, Issue 1
January 2023
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Index by author
  • Back Matter (PDF)
  • Ed Board (PDF)
  • Front Matter (PDF)
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Anticancer Research.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Association Between Body Mass Index and Outcomes in Patients With Urothelial Carcinoma Treated With Pembrolizumab
(Your Name) has sent you a message from Anticancer Research
(Your Name) thought you would like to see the Anticancer Research web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
9 + 1 =
Solve this simple math problem and enter the result. E.g. for 1+3, enter 4.
Citation Tools
Association Between Body Mass Index and Outcomes in Patients With Urothelial Carcinoma Treated With Pembrolizumab
IKKO TOMISAKI, MIRII HARADA, SHIGERU SAKANO, MICHIKAZU TERADO, RYOICHI HAMASUNA, SHUJI HARADA, HIROOMI MATSUMOTO, SOICHIRO AKASAKA, YUJIRO NAGATA, AKINORI MINATO, KEN-ICHI HARADA, NAOHIRO FUJIMOTO
Anticancer Research Jan 2023, 43 (1) 269-274; DOI: 10.21873/anticanres.16159

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Reprints and Permissions
Share
Association Between Body Mass Index and Outcomes in Patients With Urothelial Carcinoma Treated With Pembrolizumab
IKKO TOMISAKI, MIRII HARADA, SHIGERU SAKANO, MICHIKAZU TERADO, RYOICHI HAMASUNA, SHUJI HARADA, HIROOMI MATSUMOTO, SOICHIRO AKASAKA, YUJIRO NAGATA, AKINORI MINATO, KEN-ICHI HARADA, NAOHIRO FUJIMOTO
Anticancer Research Jan 2023, 43 (1) 269-274; DOI: 10.21873/anticanres.16159
Twitter logo Facebook logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • Patients and Methods
    • Results
    • Discussion
    • Acknowledgements
    • Footnotes
    • References
  • Figures & Data
  • Info & Metrics
  • PDF

Related Articles

Cited By...

  • Efficacy and Tolerability of Enfortumab Vedotin for Metastatic Urothelial Carcinoma: Early Experience in the Real World
  • Google Scholar

More in this TOC Section

  • Preoperative Cachexia Index Predicts Overall Survival Following Curative Resection for Remnant Gastric Cancer
  • Effect of Increased Image Matrix on Lung Nodule Volumetry in Chest CT: A Phantom Study
  • Prognostic Impact of the Geriatric Nutritional Risk Index in Elderly Patients With Colorectal Cancer
Show more Clinical Studies

Keywords

  • body mass index
  • pembrolizumab
  • Obesity
  • Urothelial carcinoma
Anticancer Research

© 2026 Anticancer Research

Powered by HighWire